Spok Holdings, Inc.

NASDAQ:SPOK

Medical - Healthcare Information Services

Healthcare
$10.93 +1.60%

+$0.17 today

Market cap
$228.30M
Beta
0.44
P/E (TTM)
17.2
EPS (TTM)
$0.61
Dividend yield
11.93%
52W Low $9.95High $19.31

Volume 0.18M

Average 0.17M

SPOK EBITDA Margin

EBITDA as a percentage of revenue.

Spok Holdings, Inc.NASDAQ: SPOK

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to 10.9%

EBITDA Margin was 10.9% in Q1 FY2026, down 8.7 pp from a year earlier. On a trailing-twelve-month basis it was 16.3%, down 1.8 pp year over year. Over 3 fiscal years it widened by 14.4 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 15.3% for the fiscal year ending Dec 2026, down from 17.8% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
10.9%-4.1 pp QoQ
Last fiscal yearDec 2025
17.8%+0.2 pp YoY
LTMMar 2026
16.3%-1.8 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8.7 pp-6.0 pp+2.8 pp
1 year+0.2 pp-2.5 pp-2.7 pp
3 years+14.4 pp——
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
17.8%
Year-over-year change
+0.2pp
Reported Analyst consensus estimate

EBITDA Margin vs competitors

How SPOK compares with its peers on the latest reported figures

  • SPOK's LTM Mar 2026 EBITDA Margin of 16.3% is the 4th highest of the 11 companies compared; the peer median is 2.7%.
  • Its year-over-year change of -1.8 pp is the 8th highest of 11, against a peer median of +2.2 pp.
  • Over three fiscal years its change of +14.4 pp compares with a peer median of -0.6 pp.
SPOK Competitors Peer median
EBITDA Margin for SPOK and competitors
Company Period LTM level YoY 3-year change
SLPSimulations Plus, Inc.LTM Feb 202621.5% +0.4 pp-16.1 pp
NRCNational Research CorporationLTM Mar 202620.1% -9.1 pp-10.5 pp
VMDViemed Healthcare, Inc.LTM Mar 202618.5% +0.7 pp+1.2 pp
SPOKSpok Holdings, Inc.LTM Mar 202616.3% -1.8 pp+14.4 pp
TBRGTruBridge, Inc.LTM Mar 20269.4% -3.3 pp-2.4 pp
DHDefinitive Healthcare Corp.LTM Mar 20264.9% +295.3 pp-78.9 pp
CERSCerus CorporationLTM Mar 20260.5% +5.1 pp+18.3 pp
MASS908 Devices Inc.LTM Mar 2026-46.0% +3.6 pp+16.5 pp
CGCCanopy Growth CorporationLTM Mar 2026-65.7% +112.4 pp+874.7 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-81.4% -6.3 pp+87.8 pp
SENSSenseonics Holdings, Inc.LTM Mar 2026-198.5% +73.8 pp-1165.0 pp
Peer median (excluding SPOK) 2.7%+2.2 pp-0.6 pp

Competitors are the stored peer set for SPOK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue142.15M134.53M139.03M137.65M139.71M
Cost of Revenue72.27M59.25M57.16M28.43M29.57M
Gross Profit69.89M75.28M81.87M109.22M110.14M
Gross Margin49.2%56.0%58.9%79.3%78.8%
Research & Development17.92M13.63M10.55M11.55M12.09M
Selling, General & Admin64.02M54.09M49.52M49.15M50.87M
Operating Expenses81.94M67.72M60.07M90.26M90.43M
Depreciation & Amortization10.45M3.57M4.5M4.15M3.43M
EBITDA(16.89M)4.57M26.82M24.22M24.87M
EBITDA Margin-11.9%3.4%19.3%17.6%17.8%
Operating Income(12.06M)7.57M21.8M18.97M19.71M
Operating Margin-8.5%5.6%15.7%13.8%14.1%
Interest Income320K592K1.1M1.15M820K
Interest Expense00000
Other Income / Expenses(15.28M)(6.57M)524K1.07M1.73M
Income Before Tax(27.33M)997K22.33M20.03M21.44M
Pre-Tax Margin-19.2%0.7%16.1%14.6%15.3%
Income Tax Expense(5.15M)(20.86M)6.66M5.07M5.56M
Net Income(22.18M)21.86M15.67M14.97M15.88M
Net Margin-15.6%16.2%11.3%10.9%11.4%
EPS (Basic)(1.14)1.110.790.740.77
EPS (Diluted)(1.14)1.090.770.730.75
Weighted Avg Shares19.4M19.67M19.95M20.24M20.61M
Weighted Avg Shares (Diluted)19.4M19.99M20.34M20.57M21.07M

Spok Holdings, Inc.

NASDAQ:SPOK

Intrinsic Alpha fair value

Locked

Current Price

$10.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.